Fidelity Investments’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1
Closed -$38 5319
2024
Q4
$38 Buy
+1
New +$40 ﹤0.01% 5233
2024
Q2
Sell
-1
Closed -$41 5383
2024
Q1
$41 Hold
1
﹤0.01% 5064
2023
Q4
$40 Buy
+1
New +$38 ﹤0.01% 5064
2022
Q4
Sell
-1
Closed 5358
2022
Q3
$0 Buy
+1
New +$43 ﹤0.01% 4865
2021
Q3
Sell
-1
Closed 4357
2021
Q2
$0 Buy
+1
New +$48 ﹤0.01% 4255
2020
Q2
Sell
-1
Closed 3599
2020
Q1
$0 Sell
1
-1
-50% -$40 ﹤0.01% 3629
2019
Q4
$0 Buy
2
+1
+100% +$40 ﹤0.01% 3790
2019
Q3
$0 Sell
1
-1
-50% -$38 ﹤0.01% 3781
2019
Q2
$0 Buy
2
+1
+100% +$38 ﹤0.01% 3747
2019
Q1
$0 Sell
1
-1
-50% -$40 ﹤0.01% 3627
2018
Q4
$0 Buy
+2
New +$79 ﹤0.01% 3537

Other funds holding BME

Fidelity Investments's BME Position: Q1 2025 in Review

Fidelity Investments sold out of BlackRock Health Sciences Trust (BME) in Q1 2025, closing a stake of 1 share — an estimated $38 sold.

Fidelity Investments first reported a position in BME in Q4 2018 and held it in 11 quarters. The position peaked at $41 in Q1 2024. 67 funds tracked by Wall St. Rank hold BME as of Q1 2025.

  • Fidelity Investments reported no remaining BlackRock Health Sciences Trust position as of Q1 2025 after selling out during the quarter.
  • Fidelity Investments sold 1 BlackRock Health Sciences Trust share in Q1 2025, an estimated $38.
  • Fidelity Investments first reported a position in BlackRock Health Sciences Trust in Q4 2018 and held it in 11 quarters.
  • Fidelity Investments's BlackRock Health Sciences Trust position peaked at $41 in Q1 2024.
  • 67 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2025.

Based on Fidelity Investments's 13F filing for Q1 2025, filed 12 May 2025.